GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nunzia Pharmaceutical NUNZ · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Nunzia Pharmaceutical — daily NUNZ Delayed
Market value
$30,538
Last close × shares
Volume
10k
Shares, 30 Oct 2026

About Nunzia Pharmaceutical

Its shares trade under the ticker NUNZ. It has been listed since 23 January 1995.

Nunzia Pharmaceutical Corp. engages in the acquisition of other mines by purchasing and leasing of mineral right claims. The company is headquartered in Los Angeles, California. The firm focuses on development and delivery of pharmaceutical and nutraceutical-based therapies for the behavioral symptoms of Autistic Spectrum of Disorders (ASDs) and related conditions, such as Fragile X syndrome, as well as common anxiety-based disorders. The firm has developed NUNZIA, which is a combination of 16 vitamins, minerals and herbs which directly focuses and targets the hippocampus area of the brain, where all anxiety-based disorders originate. NUNZIA improves the lives of children and families suffering from ASDs and anxiety-based disorders. The firm is developing over the counter and pharmaceutical drug formulations of NUNZIA.

Figures and description from our data supplier, not checked against the company's own report.

More about Nunzia Pharmaceutical →

Latest on Nunzia Pharmaceutical

Our reporting

We have not reported on Nunzia Pharmaceutical yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Nunzia Pharmaceutical's ticker?

Nunzia Pharmaceutical trades as NUNZ on its US listing, under ISIN US67097W1027.

What was Nunzia Pharmaceutical's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.